Head-to-head dispatch
Oak vs yourEra
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Nationwide, package-based and quick to approve, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. The catch is not secrecy but inconsistency: its advertising carries nine different "starting" prices and none of them is what it charges.
Marked down on: Oak's MARKETING layer publishes nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or billing cadence to none of them. None of the nine is what it charges: its own funnel quotes $200/mo semaglutide and $250/mo tirzepatide, one flat rate at every dose
Desk Score
A rare compounded desk that publishes its pricing outright — both molecules plus a NAD+ and microdosing menu, across all 50 states.
Marked down on: Compounded only — not FDA-approved and not equivalent to brand Wegovy/Ozempic or Zepbound; availability can tighten as brand shortages resolve
yourEra takes this head-to-head with the higher Desk Score, 84/100 (B) against 71/100 (C) for Oak. Oak still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Oak
71/100
C
yourEra
84/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Oak | yourEra |
|---|---|---|
| Semaglutide | $200/mo (one flat rate at every dose); $133/mo only on the 3-month prepay with code OAKSAVE200, billed upfront | $199/mo |
| Tirzepatide | $250/mo (one flat rate at every dose); $199/mo only on the 3-month prepay with code OAKSAVE200, billed upfront | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay. | Patients who want transparent, upfront pricing on both semaglutide and tirzepatide and value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes. |
| Desk Score | 71/100C | 84/100B |
The verdict
Desk pick — yourErayourEra takes this head-to-head with the higher Desk Score, 84/100 (B) against 71/100 (C) for Oak. Oak still holds its ground where its strengths line up with yours.
Choose Oak if…
People who want nationwide package-based care and are willing to complete a long intake before learning what they will actually pay.
$200/mo (one flat rate at every dose); $133/mo only on the 3-month prepay with code OAKSAVE200, billed upfront sema · $250/mo (one flat rate at every dose); $199/mo only on the 3-month prepay with code OAKSAVE200, billed upfront tirz · All 50 states
Choose yourEra if…
Patients who want transparent, upfront pricing on both semaglutide and tirzepatide and value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes.
$199/mo sema · $299/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Oak · yourEra.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Oak vs CoreAge Rx
- yourEra vs Vaylen
- Oak vs Strut Health
- yourEra vs Ondra Health
- Oak vs Invigor Medical
- yourEra vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.